To Get Help Now
Product Liability Lawsuits
Click Here
 
Today's Date:

FDA Warns of Tainted Weight Loss Supplements

The U.S. Food and Drug Administration (FDA) is warning consumers to not buy or use several tainted supplements promoted for weight loss or body building. Included in the FDA’s warning are: Mix Fruit Slimming; Trim-Fast Slimming Softgel; Lingzhi Cleansed Slim Tea; Sliming (sic) Diet By Pretty White; Lipo 8 Burn Slim; and 24 Ince.

The warning was issued after FDA lab analyses confirmed that sitbutramine, a controlled substance withdrawn from the market, was an active ingredient in Mix Fruit Slimming, Trim-Fast Slimming Softgel, Lingzhi Cleansed Slim Tea, Sliming (sic) Diet By Pretty White, Lipo 8 Burn Slim, and 24 Ince. More FDA Warns of Tainted Weight Loss Supplements

DePuy Must Pay Oregon $4 Million to Settle Allegations Related to its Marketing of ASR XL Hips

DePuy Orthopaedics Inc. has been ordered to pay $4 million to settle allegations by the Oregon Department of Justice (ODOJ) that the medical device maker knowingly marketed faulty ASR XL metal-on-metal (MoM) hips.

The ASR XL all-metal hip device was intended to last 15 years, but studies showed the devices failed much sooner than expected. Data collected from the National Joint Registry of England in 2010 revealed that one in every eight patients (12 percent to 13 percent) had to undergo revision surgery within five years of receiving it.The hips have caused thousands of patients to experience pain, swelling, bone and muscle damage, and difficulty walking. More DePuy Must Pay Oregon $4 Million to Settle Allegations Related to its Marketing of ASR XL Hips

OTC Acne Products Linked to Serious Skin Reactions

The U.S. Food and Drug Administration (FDA) is warning the public that certain over-the-counter (OTC) topical acne products can cause rare but serious and even life-threatening allergic reactions.

In a safety communication, the agency said consumers should “stop using their topical acne product and seek emergency medical attention immediately if they experience hypersensitivity reactions such as throat tightness; difficulty breathing; feeling faint; or swelling of the eyes, face, lips, or tongue.” Consumers are also advised to also stop using the product if they develop hives or itching. More OTC Acne Products Linked to Serious Skin Reactions

Key Ignition Problem Prompts GM to Issue 44th Vehicle Recall This Year

On Monday, General Motors (GM) announced that it would recall 3.16 million midsize and large cars to modify their ignition switches to avoid a replay of the problems that sparked a recall of 2.9 million small cars in February and March.

The faulty ignition switch has been linked to 13 deaths and 54 crashes. GM says it is aware of eight crashes and six injuries tied to the vehicles involved in the current recall, according to USAToday.com. More Key Ignition Problem Prompts GM to Issue 44th Vehicle Recall This Year

Human Sues Medtronic, Accuses the Company of Falsely Representing its Infuse Bone Growth Product

Managed care company Humana has sued Medtronic Inc., accusing the company of falsely representing its Infuse bone growth device as safe and effective in spinal fusion surgeries.

Humana filed the lawsuit in federal court in Tennessee on Friday. The complaint alleges that Medtronic paid for academic literature that fraudulently portrayed Infuse as safe and effective for off-label uses. According to court documents, Humana said that Medtronic engaged in a “sophisticated and deeply deceptive marketing strategy” designed to expand the market for Infuse, by urging and compensating spine surgeons to use the device by over-emphasizing its benefits and downplaying its serious risks, Reuters reported. More Human Sues Medtronic, Accuses the Company of Falsely Representing its Infuse Bone Growth Product

Study Links Excessive Cell Phone Use to Brain Tumors

People who use their cell phones with great frequency may be at an elevated risk of being diagnosed with a brain tumor, according to a new French study.

The study authors cautioned that it’s still not clear if there’s added risk for the majority of cell phone users, but say a link may exist between excessive cell phone use and brain tumors. They added, that since the devices and the way people use them is ever-changing, more research is needed going forward, Fox News reported. More Study Links Excessive Cell Phone Use to Brain Tumors

Atlas Chalet Shingle Class Action Moves Forward

A Georgia federal judge ruled Monday that a South Carolina couple who brought a class action against Atlas Roofing Corp. failed to adequately assert an economic loss from their purchase of Atlas Chalet shingles, as required under South Carolina law in order to prove strict liability or negligence for a product liability tort.

David and Patricia Dickson alleged in their complaint that the manufacturing process allowed moisture to enter the shingles, creating gas bubbles that expanded in the sun, blistering and cracking them, according to Law360.com. More Atlas Chalet Shingle Class Action Moves Forward

Medtronic Tries to Settle Infuse Cases but Many Patients May Still See Their Day in Court

More than 6,500 reports of injuries related to Medtronic’s Infuse bone growth product have flooded into the U.S. Food and Drug Administration (FDA) since 2002. About 3,300 were registered with the agency’s medical device reporting system last year alone. Now, the company is settling as many cases as possible while patients await their day in court.

Medtronic told investors last week that it will pay $22 million to settle about 950 claims and is setting aside $140 million to settle future claims, according to MedPageToday.com. More Medtronic Tries to Settle Infuse Cases but Many Patients May Still See Their Day in Court

Chicago Jury Decides Takeda Pharmaceutical Co. is not Responsible for Man’s Bladder Cancer Death

Takeda Pharmaceutical Co. is not responsible for the death of a man who died in 2006 after taking the Type 2 diabetes drug Actos, a jury decided yesterday.

A lawyer for the family of William Whitlach, 57, urged the jury to award at least $10 million to his wife and children for pain, suffering, and financial losses caused by his death. During the closing arguments of the four-week trial, the attorney said Takeda continued to sell its Actos even though it knew caused bladder cancer in order to maximize returns before competing generic versions reached the market, BusinessWeek.com reported. More Chicago Jury Decides Takeda Pharmaceutical Co. is not Responsible for Man’s Bladder Cancer Death

FDA Asks Public to Help Fight Battle against Tobacco Companies

The U.S. Food and Drug Administration (FDA) is asking for the public to step up and help keep children away from tobacco.

Recent data released by the agency shows that every day, more than 3,200 Americans under the age of 18 smoke a cigarette for the first time. Of that group, more than 700 become daily smokers, the FDA said. More FDA Asks Public to Help Fight Battle against Tobacco Companies